Jacobs Bruce N. — SEC Form 4 filings
SEC reporting owner CIK 1821074. 10 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-03-04 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 21 legs across 5 filings — 179,769 shares, $14,296,323 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 51,375 shares @ $114.77 ($5,896,288) in Kymera Therapeutics, Inc., filed 2026-07-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Chief Financial Officer | 10 | — | 21 legs · 179,769 sh · $14,296,323 | 21 |
Form 4 filings — Jacobs Bruce N.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-02 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 61,378 @ $5.33 · Sale (S): 1,500 @ $110.54 · Sale (S): 1,700 @ $111.57 · Sale (S): 1,100 @ $112.79 · Sale (S): 4,110 @ $114.19 · Sale (S): 51,375 @ $114.77 · +4 more | EDGAR |
| 2026-06-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 12,653 @ $2.08 · Option exercise (M): 12,653 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 15,000 @ $2.08 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 17,650 @ $0 · Sale (S): 2,039 @ $87.75 · Sale (S): 1,424 @ $88.50 · Sale (S): 4,113 @ $89.66 · Sale (S): 492 @ $84.00 · Sale (S): 2,519 @ $85.04 · +3 more | EDGAR |
| 2025-09-17 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 79,220 @ $2.08 · Sale (S): 79,220 @ $50.00 · Option exercise (M): 42,246 (derivative) @ $0 · Option exercise (M): 36,974 (derivative) @ $0 | EDGAR |
| 2025-04-01 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 25,000 @ $2.08 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 30,000 @ $0 · Sale (S): 5,754 @ $30.33 · Sale (S): 1,281 @ $31.00 · Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 10,000 @ $2.08 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-06-28 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 25,000 @ $2.08 · Option exercise (M): 25,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 31,250 @ $0 · Sale (S): 2,378 @ $41.41 · Sale (S): 1,301 @ $42.39 · Sale (S): 255 @ $43.26 · Grant/award (A): 187,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1821074 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →